Zy Therapeutics at the SWFIRN & CCN Conference: Advancing Collaboration in Sturge-Weber Research

  • Published
  • 1 min read

– September 18–20, 2025 | Madison, WI –

Zy Therapeutics is pleased to announce that our Chief Medical & Scientific Officer, Dr. Jeffrey Loeb, will be attending the Sturge-Weber Foundation Clinical Care & Research Network (SWFIRN & CCN) Conference in Madison, WI, taking place from September 18–20, 2025.

This conference represents an important opportunity to deepen collaboration between clinical science and therapeutic innovation. As a company dedicated to addressing the unmet needs in Sturge-Weber syndrome, our participation underscores our commitment to advancing transformative treatments for rare brain disorders.

We look forward to connecting, learning, and contributing meaningfully to this global community of researchers, clinicians, and advocates.